Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
BIOTUBE CO., LTD. has 2 pending office actions in the Medical Devices & Mechanical Engineering technology area. These filings are split between 2 distinct examiners and 2 distinct art units. FLORES, ADRIAN is the busiest examiner, with 1 busiest examiner pending office action. This structure shows that every 2 pending office actions for the company is being handled by a unique examiner in a unique art unit.
The distribution of these matters across 2 distinct art units suggests that the company's medical device technology spans different specialized classifications within the patent office. Because there are 2 distinct examiners involved, the prosecution experience is diversified, and the company must address the specific requirements of different groups simultaneously. This lack of concentration even in a small portfolio indicates a broad technical footprint.
With the busiest examiner handling 1 busiest examiner pending office action, the workload is evenly divided. Practitioners should expect independent prosecution paths for each application, as the 2 distinct art units likely have different examination cultures and priorities. The pending office actions represent separate challenges that require tailored responses for each of the examiners currently reviewing the company's work.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FLORES, ADRIAN | 1 | 100.0% | +0.0% |
| EBBINGHAUS, BRIANA NOEL | 1 | 61.6% | +63.5% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18686816 | TISSUE BODY FORMATION DEVICE AND TISSUE BODY FORMATION METHOD | FLORES, ADRIAN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18010667 | SOMATIC STEM CELL-ACCUMULATED TISSUE CONSTRUCT AND DEVICE FOR PRODUCING THE SAME | EBBINGHAUS, BRIANA NOEL | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18010667 | SOMATIC STEM CELL-ACCUMULATED TISSUE CONSTRUCT AND DEVICE FOR PRODUCING THE SAME | EBBINGHAUS, BRIANA NOEL | — |
| Art Unit | Apps |
|---|---|
| 3774 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18686816 | TISSUE BODY FORMATION DEVICE AND TISSUE BODY FORMATION METHOD | FLORES, ADRIAN | 3774 | §103 | Non-Final OA | — | Pending | Feb 26, 2024 |
| 18010667 | SOMATIC STEM CELL-ACCUMULATED TISSUE CONSTRUCT AND DEVICE FOR PRODUCING THE SAME | EBBINGHAUS, BRIANA NOEL | 1632 | §102§103§112Other | Final Rejection | — | Pending | Dec 15, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial